ANIK
Anika Therapeutics Inc
Price:  
26.28 
USD
Volume:  
61,366.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Anika WACC - Weighted Average Cost of Capital

The WACC of Anika Therapeutics Inc (ANIK) is 5.5%.

The Cost of Equity of Anika Therapeutics Inc (ANIK) is 6.95%.
The Cost of Debt of Anika Therapeutics Inc (ANIK) is 5.00%.

Range Selected
Cost of equity 5.40% - 8.50% 6.95%
Tax rate 18.90% - 22.40% 20.65%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.7% - 6.2% 5.5%
WACC

Anika WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.34 0.64
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.40% 8.50%
Tax rate 18.90% 22.40%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.7% 6.2%
Selected WACC 5.5%